SCHEMBL6941727

SCHEMBL6941727

CC(=O)N(NC(=O)[C@H](CC(C)C)[C@H](CC=Cc1ccccc1)C(=O)NOC1CCCCO1)c1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.42
TRPM8 Q7Z2W7 5/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TGFBR1 P36897 1/20 0.34
P2RX3 P56373 1/20 0.32
CNR2 P34972 2/20 0.32
MMP2 P08253 3/20 0.32
MMP9 P14780 2/20 0.32
ANPEP P15144 2/20 0.32
LTA4H P09960 1/20 0.32
LAP3 P28838 1/20 0.32
NPEPPS P55786 1/20 0.32
ERAP2 Q6P179 1/20 0.32
ERAP1 Q9NZ08 1/20 0.32
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31
CCNA1 P78396 1/20 0.31
CDK5 Q00535 1/20 0.31
CDK5R1 Q15078 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6940169 0.90 ADAM17 (0.45) ADAM17TGFBR1P2RX3MMP2MMP9
SCHEMBL6946888 0.89 ADAM17 (0.48) ADAM17TRPM8ALDH1A1SMN1; SMN2TGFBR1
SCHEMBL6983650 0.84 ADAM17 (0.44) ADAM17TGFBR1P2RX3MMP2MMP9
SCHEMBL6981370 0.84 ADAM17 (0.44) ADAM17TGFBR1P2RX3MMP2MMP9
SCHEMBL7835552 0.84 ADAM17 (0.44) ADAM17ALDH1A1TGFBR1P2RX3MMP2
SCHEMBL7955132 0.84 ADAM17 (0.44) ADAM17ALDH1A1TGFBR1P2RX3MMP2
SCHEMBL6945376 0.83 ADAM17 (0.49) ADAM17TGFBR1P2RX3CNR2MMP2
SCHEMBL6945370 0.83 ADAM17 (0.49) ADAM17TGFBR1P2RX3CNR2MMP2
SCHEMBL6942910 0.83 ADAM17 (0.43) ADAM17ALDH1A1TGFBR1P2RX3MMP2
SCHEMBL6939853 0.83 ADAM17 (0.53) ADAM17SMN1; SMN2TGFBR1P2RX3CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed
EP-0993442-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-04-19 EP disclosed
WO-1999001428-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-01-14 WO disclosed